Smoking Cessation Trial
March 2024
NDARC has completed the largest active comparator cytisine trial for smoking cessation. The NDARC Tobacco Research Group has led a joint consultation alongside APSAD to support cytisine availability for Australian smokers.
Read more about this trial here.